
INVA vs RARE
$INVA vs $RARE head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
INVA vs RARE: the quick read
- ·RARE is the larger company by market cap ($1.50B vs $1.48B).
- ·RARE has been more active on our scanner (199 vs 25 alerts in 30 days).
- ·INVA has the smaller float (68.8M vs 98.0M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Pharmaceutical Preparations vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·RARE draws far more of our scanner's attention, 199 unusual-volume alerts in 30 days against 25, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·INVA pays a dividend and RARE does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing INVA and RARE on TheDesperateTrader.
- Is INVA or RARE the better stock?
- "Better" depends on your goal, and these two are not alike. RARE is the larger company by market cap ($1.50B vs $1.48B). RARE has been more active on our scanner (199 vs 25 alerts in 30 days). INVA has the smaller float (68.8M vs 98.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between INVA and RARE?
- The differences that matter: they are not in the same business - INVA is pharmaceutical preparations and RARE is pharmaceutical preparations; they are similar in size ($1.48B vs $1.50B); they trade at very different share prices ($20.50 vs $15.05); INVA sits at 46% of its 52-week range against 9% for RARE; only INVA pays a dividend; our scanner flagged INVA 25 times in the last 30 days against 199 for RARE. Everything above is measured from the latest completed session and SEC filings.
- Which of INVA and RARE is more active right now?
- Right now INVA is at about 0.9x its normal volume and RARE is at about 0.7x, so INVA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading INVA or RARE? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore INVA and RARE comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.